BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Al Danaf L, Hussein Kamareddine M, Fayad E, Hussain A, Farhat S. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis. World J Hepatol 2022; 14(4): 744-753 [PMID: 35646268 DOI: 10.4254/wjh.v14.i4.744]
URL: https://www.wjgnet.com/1948-5182/full/v14/i4/744.htm
Number Citing Articles
1
Agostino Di Ciaula, Harshitha Shanmugam, Rogério Ribeiro, Ana Pina, Rita Andrade, Leonilde Bonfrate, João F. Raposo, M. Paula Macedo, Piero Portincasa. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver diseaseEuropean Journal of Internal Medicine 2023; 107: 52 doi: 10.1016/j.ejim.2022.10.024
2
Amal A. Mohamed, Rania Al Dweik, Reem A. Abdelghafour, Ahmed Ramadan, Abbas M. Abbas, Hussein H. Samir, Nashwa M. Muharram, Randa Ibrahim Ahmed Elshiha, Naglaa El-Salawy, Doaa Ghaith, Marwa K. Darwish, Soha M. Abd El Salam, Eman A. Sultan, Amina S. Soliman, Mohamed Ezz AL Arab, Ahmed Yosri Elamir, Ahmed Ali Mohamed, Al-Shaymaa A. Hassanin, Alaa Ali Mohamed Abouaggour, Wael Hafez, Mohamed M. Omran. Anthropometry, laboratory, and PNPLA3 polymorphisms in a novel model for early identification and evaluation of nonalcoholic fatty liver diseaseInformatics in Medicine Unlocked 2024; 48: 101513 doi: 10.1016/j.imu.2024.101513
3
Jeanne M. Clark, Donna R. H. Cryer, Michelle Morton, Jay H. Shubrook. Nonalcoholic fatty liver disease from a primary care perspectiveDiabetes, Obesity and Metabolism 2023; 25(6): 1421 doi: 10.1111/dom.15016